Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hereditary Haemochromatosis”

70 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 70 results

Large-scale testing (Phase 3)Study completedNCT00440986
What this trial is testing

Clinical Management of Hereditary Hemochromatosis: Phlebotomy vs. Erythrocytoapheresis

Who this might be right for
Hereditary Hemochromatosis
San Filippo Neri General Hospital 25
Testing effectiveness (Phase 2)Looking for participantsNCT07332091
What this trial is testing

Efficacy and Safety of Vamifeport in Adult Participants With Homeostatic Iron Regulator Gene (HFE)-Related Hereditary Hemochromatosis

Who this might be right for
Homeostatic Iron Regulator Gene-related Hereditary Hemochromatosis
CSL Behring 84
Testing effectiveness (Phase 2)Ended earlyNCT02263638
What this trial is testing

Treatment of Refractory Hemochromatosis Rheumatism by Anakinra: a Preliminary Phase II Study

Who this might be right for
Refractory Hemochromatosis Rheumatism
Rennes University Hospital 17
Not applicableStudy completedNCT02025543
What this trial is testing

Confounder-Corrected Quantitative MRI Biomarker of Hepatic Iron Content

Who this might be right for
Iron OverloadHemochromatosisHemosiderosis
University of Wisconsin, Madison 207
Not applicableUnknownNCT01935661
What this trial is testing

A Case Control Study to Evaluate the Cognitive and Brain Function of β-thalassemia Patients.

Who this might be right for
ThalassemiaBrain Function (Measured by ERP Level)
HaEmek Medical Center, Israel 120
Testing effectiveness (Phase 2)Study completedNCT00000595
What this trial is testing

Evaluation of Subcutaneous Desferrioxamine as Treatment for Transfusional Hemochromatosis

Who this might be right for
Anemia (Iron-Loading)Beta-ThalassemiaHematologic Diseases+4 more
National Heart, Lung, and Blood Institute (NHLBI)
Not applicableStudy completedNCT01784939
What this trial is testing

HEPFER-Evaluation of a New Phenotypic Biological Marker in Genetic Type 1 Hemochromatosis

Who this might be right for
Hereditary Hemochromatosis C282Y Homozygous
Rennes University Hospital 31
Not applicableStudy completedNCT02099214
What this trial is testing

Estimation of Myocardial Iron Overload by 3 Tesla MRI in HFE Hereditary Haemochromatosis

Who this might be right for
Myocardial Iron OverloadHFE-Associated Hereditary Hemochromatosis
Rennes University Hospital 66
Not applicableStudy completedNCT00199628
What this trial is testing

Research Network for Neonatal Diseases Induced by Tissular Fetomaternal Alloimmunization

Who this might be right for
Glomerulonephritis, MembranousNeonatal Diseases and AbnormalitiesHemochromatosis
University Hospital, Limoges 100
Large-scale testing (Phase 3)Study completedNCT00061750
What this trial is testing

Safety & Efficacy of ICL670 vs. Deferoxamine in Beta-thalassemia Patients With Iron Overload Due to Blood Transfusions

Who this might be right for
Beta-Thalassemia
Novartis Pharmaceuticals 595
Not applicableStudy completedNCT00213772
What this trial is testing

Risk Factors of Porphyria Cutanea Tarda (PCT)

Who this might be right for
Porphyria Cutanea Tarda
University Hospital, Strasbourg, France 280
Large-scale testing (Phase 3)Ended earlyNCT00981370
What this trial is testing

Clinical Importance of Treating Iron Overload in Sickle Cell Disease

Who this might be right for
Anemia, Sickle CellTransfusion Hemosiderosis
Children's Hospital Los Angeles 1
Large-scale testing (Phase 3)Study completedNCT00190385
What this trial is testing

Screening of Hepatocellular Carcinoma in Patients With Compensated Cirrhosis

Who this might be right for
Compensated Cirrhosis
Assistance Publique - Hôpitaux de Paris 1,200
Testing effectiveness (Phase 2)Study completedNCT00061763
What this trial is testing

Study of Deferasirox in Iron Overload From Beta-thalassemia Unable to be Treated With Deferoxamine or Chronic Anemias

Who this might be right for
Beta-thalassemiaMyelodysplastic SyndromesFanconi Syndrome+2 more
Novartis Pharmaceuticals 175
Testing effectiveness (Phase 2)Study completedNCT01044186
What this trial is testing

A Protocol to Allow Treatment With ICL670 for Patients With or at Risk of Life-threatening Complications of Transfusional Iron Overload Who Are Unable to Tolerate Other Iron Chelators Because of Documented Severe Toxicity

Who this might be right for
Transfusional Iron Overload
Novartis Pharmaceuticals 30
Not applicableLooking for participantsNCT03131427
What this trial is testing

China Registry for Genetic / Metabolic Liver Diseases

Who this might be right for
Genetic/Metabolic Liver Diseases
Beijing Friendship Hospital 20,000
Testing effectiveness (Phase 2)WithdrawnNCT01892644
What this trial is testing

Treatment of Iron Overload With Deferasirox (Exjade) in Hereditary Hemochromatosis and Myelodysplastic Syndrome

Who this might be right for
HemochromatosisMyelodysplastic Syndromes
Haukeland University Hospital
Not applicableUnknownNCT01524757
What this trial is testing

Proton Pump Inhibitors in the Prevention of Iron Reaccumulation in Patient With Hereditary Hemochromatosis

Who this might be right for
Hemochromatosis
Maastricht University Medical Center 48
Not applicableStudy completedNCT02007746
What this trial is testing

Liver Fibrosis in Sickle Cell Disease

Who this might be right for
Sickle Cell Disease
University of Miami 26
Large-scale testing (Phase 3)Study completedNCT00171171
What this trial is testing

Long-term Treatment With Deferasirox in Patients With Beta-thalassemia and Transfusional Hemosiderosis

Who this might be right for
Beta-ThalassemiaHemosiderosis
Novartis 252
Next Page